PRESS RELEASE published on 01/29/2025 at 19:03, 1 year 4 months ago AB Science today provides an update on its masitinib platform AB Science provides update on masitinib platform for ALS, MS, and AD. Positive results show potential for huge market sales. Debt negotiation planned Update AB Science Masitinib Platform Market Sales Debt Negotiation
BRIEF published on 01/24/2025 at 18:06, 1 year 4 months ago AB Science to Present Masitinib Update in Upcoming Webcast Pharmaceuticals Webcast Research Update AB Science Masitinib
BRIEF published on 01/24/2025 at 18:06, 1 year 4 months ago AB Science présentera une mise à jour sur le masitinib lors d'un prochain webcast Webcast Médicaments Masitinib Mise À Jour De La Recherche Sciences AB
PRESS RELEASE published on 01/24/2025 at 18:01, 1 year 4 months ago AB Science will host a live webcast on Tuesday January 28, 2025, from 5.30pm to 6.45pm CET AB Science to host live webcast on masitinib platform update on January 28, 2025, 5.30pm CET. Leading pharmaceutical company specializing in protein kinase inhibitors Pharmaceutical Company Live Webcast AB Science Protein Kinase Inhibitors Masitinib Platform
PRESS RELEASE published on 01/24/2025 at 18:01, 1 year 4 months ago AB Science tiendra une conférence virtuelle le mardi 28 janvier 2025, de 17h30 à 18h45 AB Science tiendra une conférence virtuelle le mardi 28 janvier 2025 pour présenter la plateforme masitinib. Des intervenants de renom seront présents. Plus d'informations sur www.ab-science.com Conférence Virtuelle Plateforme AB Science Masitinib Intervenants
BRIEF published on 01/22/2025 at 19:04, 1 year 4 months ago AB Science Participates in Biomed Forum Investors Conference Investor Conference BIOMED Forum AB Science Masitinib Protein Kinase Inhibitors
BRIEF published on 01/22/2025 at 19:04, 1 year 4 months ago AB Science participe à la conférence des investisseurs du Biomed Forum Conférence Des Investisseurs Masitinib Sciences AB Forum Biomédecine Inhibiteurs De La Protéine Kinase
PRESS RELEASE published on 01/22/2025 at 18:59, 1 year 4 months ago AB Science will participate in the Biomed Forum investors conference AB Science to participate in Biomed Forum Investors Conference organized by AllInvest Securities in Paris on February 4, 2025 Pharmaceutical Company BIOMED Forum AB Science Investors Conference AllInvest Securities
PRESS RELEASE published on 01/22/2025 at 18:59, 1 year 4 months ago AB Science participera à la conférence investisseurs Biomed Forum AB Science participera à la conférence investisseurs Biomed Forum à Paris. Présentation de la société pharmaceutique spécialisée dans les IPK. Déclarations prospectives incluses BIOMED Forum Déclarations Prospectives Pharmaceutique AB Science IPK
BRIEF published on 12/17/2024 at 19:09, 1 year 6 months ago AB Science présente les avancées d'AB8939 pour la leucémie aiguë myéloïde Phase 1 AB8939 Leucémie Myéloïde Aiguë Résistance Médicamenteuse Marché Potentiel
Published on 06/19/2026 at 04:30, 14 hours 52 minutes ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 18 hours 2 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 18 hours 15 minutes ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 19 hours 22 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/19/2026 at 19:01, 21 minutes ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 18:00, 1 hour 22 minutes ago Successful issue of a CHF 100 million green bond
Published on 06/19/2026 at 17:45, 1 hour 37 minutes ago Linedata Services: Déclaration des transactions sur actions propres Opération du 18 juin 2026
Published on 06/19/2026 at 17:40, 1 hour 42 minutes ago Infotel : Mise en œuvre d’une convention de rachat d’actions.
Published on 06/19/2026 at 14:40, 4 hours 42 minutes ago 260619 BENETEAU Mise en oeuvre Programme rachat d'actions
Published on 06/19/2026 at 08:55, 10 hours 27 minutes ago ALPOU - Groupe POULAILLON - Communiqué mise à disposition de la note d'information et DAI relatif à la société visée
Published on 06/19/2026 at 08:55, 10 hours 27 minutes ago ALPOU - Groupe POULAILLON - Communiqué mise à disposition de la note d'information et DAI relatif à EUGENIE
